---
layout: post
title: "Endocrine Disruptor Screening Program (EDSP); Near-Term Strategies for Implementation; Notice of Availability and Request for Comment; Extension of Comment Period"
date: 2026-02-05 18:57:56 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-27405
original_published: 2023-12-14 00:00:00 +0000
significance: 8.00
---

# Endocrine Disruptor Screening Program (EDSP); Near-Term Strategies for Implementation; Notice of Availability and Request for Comment; Extension of Comment Period

**Published:** February 05, 2026 18:57 UTC
**Source:** Federal Register
**Original Published:** December 14, 2023 00:00 UTC
**Document Number:** 2023-27405

## Summary

In the Federal Register of October 27, 2023, EPA announced the availability of and solicited comment on near-term strategies to help the Agency meet its obligations and commitments under the Federal Food, Drug, and Cosmetic Act (FFDCA), which requires, that EPA screen for and protect against endocrine disrupting effects in humans. This document extends the comment period, which was scheduled to end on December 26, 2023, for 60 days.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/12/14/2023-27405/endocrine-disruptor-screening-program-edsp-near-term-strategies-for-implementation-notice-of)
- API: https://www.federalregister.gov/api/v1/documents/2023-27405

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
